Table 3.

Susceptibility of most common Gram-positive pathogens isolated from the infection site (ME population)

Baseline pathogen	No. of isolates	MIC90 (rangea), in μg/ml
		TD-1792	Vancomycin
TD-1792 treatment group
Staphylococci	47	0.015 (0.002–0.015)	1 (≤0.25–1.0)
MRSA	36	0.015 (0.008–0.015)	1 (0.5–1.0)
MSSA	11	0.008 (0.002–0.015)	1 (≤0.25–1.0)
Staphylococcus epidermidis	1	0.015 (—)	2 (—)
Streptococcus agalactiae	1	0.002 (—)	0.5 (—)
Streptococcus anginosus	1	<0.001 (—)	0.5 (—)
Vancomycin treatment group
Staphylococci	48	0.015 (0.004–0.015)	1 (0.5–1.0)
MRSA	34	0.015 (0.008–0.015)	1 (—)
MSSA	14	0.008 (0.002–0.015)	1 (0.5–1)
Streptococcus agalactiae	3	0.001 (—)	0.5 (—)
Streptococcus anginosus	1	0.002 (—)	0.5 (—)

^a—, not available.